Picton Mahoney Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-139,360
Closed -$30.2M 973
2021
Q1
$30.2M Buy
+139,360
New +$26.2M 1.44% 12

Other funds holding GWPH

Picton Mahoney Asset Management's GWPH Position: Q2 2021 in Review

Picton Mahoney Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 139,360 shares — an estimated $30.2M sold.

Picton Mahoney Asset Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $30.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Picton Mahoney Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 139,360 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $30.2M.
  • Picton Mahoney Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Picton Mahoney Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $30.2M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.